CCR5 and HIV infectious disease: Second, heterozygosity and homozygosity of the CCR5-Δ32-containing HHG*2 haplotype associate with partial vs. complete reductions in CCR5 expression levels, respectively, and these expression patterns in turn contribute to their protective effects in HIV infection [31], [32].